UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Sickle cell and autoimmune disease: a double whammy

Haematologica (Roma), 2024-05

De Kreuk, Arne M.

2024

Volltextzugriff (PDF)

Allo-Immunisation in Sickle Cell Patients in a Large British Specialist Haemoglobinopathy Centre

Blood, 2019-11, Vol.134 (Supplement_1), p.2451-2451

2019

Volltextzugriff (PDF)

Natural History and Clinical Outcomes of Patients with Sickle Cell Disease: The Burden of Avascular Necrosis in a British Cohort

Blood, 2023-11, Vol.142 (Supplement 1), p.3887-3887

2023

Volltextzugriff (PDF)

Mucositis-associated bloodstream infections in adult haematology patients with fever during neutropenia: risk factors and the impact of mucositis severity

Supportive care in cancer, 2024-09, Vol.32 (9), p.579, Article 579

2024

Volltextzugriff (PDF)

Short versus extended treatment with a carbapenem in patients with high-risk fever of unknown origin during neutropenia: a non-inferiority, open-label, multicentre, randomised trial

The Lancet. Haematology, 2022-08, Vol.9 (8), p.e563-e572

2022

Volltextzugriff (PDF)

Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trial

The Lancet. Haematology, 2022-10, Vol.9 (10), p.e733-e744

2022

Volltextzugriff (PDF)

Treatment strategies for polycythemia vera: Observations in a Dutch “real‐world” cohort study

European journal of haematology, 2019-11, Vol.103 (5), p.453-459

2019

Volltextzugriff (PDF)

199. Short versus Extended Antibiotic Treatment with a Carbapenem for High-risk Febrile Neutropenia in Hematology Patients with Fever of Unknown Origin: A Randomized Multicenter Noninferiority Trial

Open forum infectious diseases, 2020-12, Vol.7 (Supplement_1), p.S228-S229

2020

Volltextzugriff (PDF)

In vitro safety profile of G-CSF-mobilized whole blood after storage for 7 days in an infusable-grade L15 medium

Transfusion (Philadelphia, Pa.), 2002-04, Vol.42 (4), p.433-442

2002

Volltextzugriff (PDF)

Granulocyte colony-stimulating factor mobilized whole blood containing over 0.3 x 10(6)/kg CD34(+) cells is a sufficient graft in autologous transplantation for relapsed

British journal of haematology, 2002-07, Vol.118 (1), p.90

2002

Volltextzugriff (PDF)

Granulocyte colony‐stimulating factor mobilized whole blood containing over 0·3 × 10 6 /kg CD34 + cells is a sufficient graft in autologous transplantation for relapsed non‐Hodgkin's lymphoma

British journal of haematology, 2002-07, Vol.118 (1), p.90-100

2002

Volltextzugriff (PDF)

Granulocyte colony‐stimulating factor mobilized whole blood containing over 0·3 × 106/kg CD34+ cells is a sufficient graft in autologous transplantation for relapsed non‐Hodgkin's lymphoma

British journal of haematology, 2002-07, Vol.118 (1), p.90-100

2002

Volltextzugriff (PDF)

Granulocyte colony-stimulating factor mobilized whole blood containing over 0.3 x 106/kg CD34+ cells is a sufficient graft in autologous transplantation for relapsed non-Hodgkin's lymphoma

British journal of haematology, 2002-07, Vol.118 (1), p.90-100

2002

Volltextzugriff (PDF)

A single-step colony-forming unit assay for unseparated mobilized peripheral blood, cord blood, and bone marrow

Journal of hematotherapy & stem cell research, 2001-12, Vol.10 (6), p.795-806

2001

Volltextzugriff (PDF)

Short Versus Extended Treatment with a Carbapenem in Haematology Patients with High Risk Fever of Unknown Origin During Neutropenia: An Open-Label Multicentre Randomised Clinical Trial

SSRN Electronic Journal

Volltextzugriff (PDF)

1 – 15 von 15

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(13)
Mit Volltextzugriff
(13)

Publikationsform

Artikel
(15)

Sprache

Englisch
(15)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Sickle cell and autoimmune disease: a double whammy

Allo-Immunisation in Sickle Cell Patients in a Large British Specialist Haemoglobinopathy Centre

Natural History and Clinical Outcomes of Patients with Sickle Cell Disease: The Burden of Avascular Necrosis in a British Cohort

Mucositis-associated bloodstream infections in adult haematology patients with fever during neutropenia: risk factors and the impact of mucositis severity

Short versus extended treatment with a carbapenem in patients with high-risk fever of unknown origin during neutropenia: a non-inferiority, open-label, multicentre, randomised trial

Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trial

Treatment strategies for polycythemia vera: Observations in a Dutch “real‐world” cohort study

199. Short versus Extended Antibiotic Treatment with a Carbapenem for High-risk Febrile Neutropenia in Hematology Patients with Fever of Unknown Origin: A Randomized Multicenter Noninferiority Trial

In vitro safety profile of G-CSF-mobilized whole blood after storage for 7 days in an infusable-grade L15 medium

Granulocyte colony-stimulating factor mobilized whole blood containing over 0.3 x 10(6)/kg CD34(+) cells is a sufficient graft in autologous transplantation for relapsed

Granulocyte colony‐stimulating factor mobilized whole blood containing over 0·3 × 10 6 /kg CD34 + cells is a sufficient graft in autologous transplantation for relapsed non‐Hodgkin's lymphoma

Granulocyte colony‐stimulating factor mobilized whole blood containing over 0·3 × 106/kg CD34+ cells is a sufficient graft in autologous transplantation for relapsed non‐Hodgkin's lymphoma

Granulocyte colony-stimulating factor mobilized whole blood containing over 0.3 x 106/kg CD34+ cells is a sufficient graft in autologous transplantation for relapsed non-Hodgkin's lymphoma

A single-step colony-forming unit assay for unseparated mobilized peripheral blood, cord blood, and bone marrow

Short Versus Extended Treatment with a Carbapenem in Haematology Patients with High Risk Fever of Unknown Origin During Neutropenia: An Open-Label Multicentre Randomised Clinical Trial

Suchergebnisse filtern